Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans
- PMID: 21852243
- PMCID: PMC3196889
- DOI: 10.1093/hmg/ddr367
Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans
Abstract
Genome-wide association studies (GWAS) have revealed 19 common genetic variants that are associated with breast cancer risk. Testing of the index signals found through GWAS and fine-mapping of each locus in diverse populations will be necessary for characterizing the role of these risk regions in contributing to inherited susceptibility. In this large study of breast cancer in African-American women (3016 cases and 2745 controls), we tested the 19 known risk variants identified by GWAS and replicated associations (P < 0.05) with only 4 variants. Through fine-mapping, we identified markers in four regions that better capture the association with breast cancer risk in African Americans as defined by the index signal (2q35, 5q11, 10q26 and 19p13). We also identified statistically significant associations with markers in four separate regions (8q24, 10q22, 11q13 and 16q12) that are independent of the index signals and may represent putative novel risk variants. In aggregate, the more informative markers found in the study enhance the association of these risk regions with breast cancer in African Americans [per allele odds ratio (OR) = 1.18, P = 2.8 × 10(-24) versus OR = 1.04, P = 6.1 × 10(-5)]. In this detailed analysis of the known breast cancer risk loci, we have validated and improved upon markers of risk that better characterize their association with breast cancer in women of African ancestry.
Figures


References
-
- Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087–1093. doi:10.1038/nature05887. - DOI - PMC - PubMed
-
- Stacey S.N., Manolescu A., Sulem P., Rafnar T., Gudmundsson J., Gudjonsson S.A., Masson G., Jakobsdottir M., Thorlacius S., Helgason A., et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 2007;39:865–869. doi:10.1038/ng2064. - DOI - PubMed
-
- Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., Wacholder S., Wang Z., Welch R., Huntchinson A., et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007;39:870–874. doi:10.1038/ng2075. - DOI - PMC - PubMed
-
- Stacey S.N., Manolescu A., Sulem P., Thorlacius S., Gudjonsson S.A., Jonsson G.F., Jakobsdottir M., Bergthorsson J.T., Gudmundsson J., Aben K.K., et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 2008;40:703–706. doi:10.1038/ng.131. - DOI - PubMed
-
- Zheng W., Long J., Gao Y.T., Li C., Zheng Y., Xiang Y.B., Wen W., Levy S., Deming S.L., Haines J.L., et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet. 2009;41:324–328. doi:10.1038/ng.318. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01-CA73629/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- RFA CA-95-011/CA/NCI NIH HHS/United States
- R01-CA63464/CA/NCI NIH HHS/United States
- U01-CA69417/CA/NCI NIH HHS/United States
- R01-CA132839/CA/NCI NIH HHS/United States
- P50-CA58223/CA/NCI NIH HHS/United States
- P30-ES10126/ES/NIEHS NIH HHS/United States
- R01-CA100598/CA/NCI NIH HHS/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- R01-CA77305/CA/NCI NIH HHS/United States
- R01-CA100374/CA/NCI NIH HHS/United States
- R37-CA54281/CA/NCI NIH HHS/United States
- N01-HD-3-3175/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases